Linda Fairstein / Flickr

Central Park Five Prosecutor Linda Fairstein Losing Publisher, Awards, Forced to Resign from Boards

After helping to wrongfully convict the Central Park Five profiled in Netflix’s “When They See Us,” a miniseries directed by Ava DuVernay, Linda Fairstein has been dropped by her publisher, Dutton.

Fairstein was the top Manhattan sexual crimes prosecutor in the 1989 case where five Black and Latino teens were wrongfully charged in the rape and beating of a white female jogger in New York City.

The teens’ confessions were coerced and their convictions were overturned in 2002 after a convicted murderer and serial rapist Matias Reyes confessed to committing the crime alone and DNA linked him to it.

Fairstein observed the boys’ 1989 interrogation which was conducted by another prosecutor and police. She didn’t personally try the case, but she was a key character in “When They See Us.”

Fairstein went from prosecutor to best-selling crime novelist. But karma is finally catching up to her.

According to The Guardian, a Dutton spokeswoman confirmed that it had “terminated its relationship” with Fairfield. Fairstein also had to resign from at least two not-for-profit boards as backlash intensified and a #CancelLindaFairstein movement spread on social media.

Last year, the Mystery Writers of America made the rare choice of withdrawing a lifetime achievement after other authors protested, citing Fairstein’s role in the Central Park racially divisive case.

Despite the evidence that the innocent boys were racially profiled and targeted, Fairstein has denied the teens were coerced and has defended authorities’ conduct in the case. The city of New York has never admitted any wrongdoing, even though the teens spent years in jail.

Latest News

Novartis Chief Medical Officer John Tsai on Balancing Medical Innovations With Patient Needs

Originally published at novartis.com by Elizabeth Dougherty. John Tsai is Novartis’ Head of Global Drug Development and Chief Medical Officer. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   John Tsai’s career as a physician, and now as Head of Global Drug Development and Chief Medical Officer for Novartis, had an unlikely…

Global Diversity

Despite Massive Uptick in Global DEI Initiatives, New Study Reveals Real Change in Corporate Workforces Remains Slow 

Even though DEI as a business imperative continues to grow both in the United States and around the world, a new study has found that many business leaders and executives have merely raised awareness of why diversity, equity and inclusion is important — as opposed to actually making meaningful progress…

Novartis Collaborates With Microsoft To Innovate Medicine Through Data and Artificial Intelligence

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   “We are not just discoverers. We actually create molecules that have never been made before.” Says Karin Briner, Head of Global Discovery Chemistry at Novartis Institutes for BioMedical Research (NIBR). By collaborating with Microsoft and augmenting the expertise of our…

Mastercard Announces Launch of Crescent City Card Program in Partnership With New Orleans and MoCaFi

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   New Orleans Mayor LaToya Cantrell was joined by executives from Mastercard, Mobility Capital Finance, Inc. (MoCaFi), and Forward Together New Orleans to announce the Crescent City Card Program. The program involves a…

Mastercard on Supporting Inclusive and Sustainable Urban Development by Expanding Its ‘City Possible’ Network

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Mastercard has continued to expand its support for addressing urban challenges and inequalities, working with city leaders and partners around the world, through the City Possible™ network and capabilities. The unique solutions…